ACS patients treated with OAP
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Treatment of Acute Coronary Syndrome (ACS).
Conditions
Treatment of Acute Coronary Syndrome (ACS).
Trial Timeline
Sep 1, 2014 → Jan 1, 2015
NCT ID
NCT02190123About ACS patients treated with OAP
ACS patients treated with OAP is a pre-clinical stage product being developed by AstraZeneca for Treatment of Acute Coronary Syndrome (ACS).. The current trial status is completed. This product is registered under clinical trial identifier NCT02190123. Target conditions include Treatment of Acute Coronary Syndrome (ACS)..
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02190123 | Pre-clinical | Completed |
Competing Products
20 competing products in Treatment of Acute Coronary Syndrome (ACS).